Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis

References

• Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003; 98: 1531–9
   PubMed Web of Science ®Google Scholar
• Slavin RE, Dias MA, Saral R. Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. Cancer 1978; 42: 1747–59
   PubMed Web of Science ®Google Scholar
• Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004; 100(Suppl 9)2026–46
   PubMed Web of Science ®Google Scholar
• Sartori S, Trevisani L, Nielsen I, Tassinari D, Abbasciano V. Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. Cancer 1996; 78: 1447–82
   PubMed Web of Science ®Google Scholar
• Sartori S, Trevisani L, Nielsen I, Tassinari D, Panzini I, Abbasciano V. Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury. J Clin Oncol 2000; 18: 463–7
   PubMed Web of Science ®Google Scholar
• Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury. Cancer 2004; 100: 1995–25
   PubMed Web of Science ®Google Scholar
• Grem JL. Fluorinated pyrimidines. Cancer chemotherapy: principles and practice, B Chabner, J Collins. Lippincott, Philadelphia 1990; 180
   Google Scholar
• Shirasaka T, Taguti T. Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept. Jpn J Cancer Chemother 2006;33:4–18 ( in Japanese).
   PubMedGoogle Scholar
• Korenaga D, Honda M, Yasuda M, Inutsuka S, Nozoe T, Tashiro H. Increased intestinal permeability correlates with gastrointestinal toxicity among formulations of the fluorouracil analogue tegafur in rats. Eur Surg Res 2002; 58: 351–6
   Web of Science ®Google Scholar
• Pritchard DM, Potten CS, Hickman JA. The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res 1998; 58: 5453–65
   PubMed Web of Science ®Google Scholar
• Pritchard DM, Watson AJ, Potten CS, Jackman AL, Hickman JA. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc Natl Acad Sci USA 1997; 94: 1795–9
   PubMed Web of Science ®Google Scholar
• Tanaka A, Koji T. Prophylactic effect of L-glutamine against intestinal derangement induced 5-fluorouracil or indomethacin in rats. Jpn Pharmacol Ther 2002; 30: 455–62
   Google Scholar
• Azuumi Y, Ohara S, Ishihara K, Okabe H, Hotta K. Correlation of quantitative change of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. Gut 1980; 21: 533–7
   PubMed Web of Science ®Google Scholar
• Ikezawa T, Ichikawa T, Adachi K, Sugano S, Ojima T, Nakamura Y, et al. Analysis of mucin composition in gastric juices of chronic rheumatic patients with upper gastrointestinal damage. Biomed Res 2005; 26: 147–51
   PubMed Web of Science ®Google Scholar
• KojimaY Ishihara K, Komuro Y, Saigenji K, Hotta K. Effects of the M1 muscarinic receptor antagonist pirenzepine on gastric mucus glycoprotein in rats with or without ethanol-induced gastric damage. Scand J Gastroenterol 1992; 27: 764–8
   PubMed Web of Science ®Google Scholar
• Ikezawa T, Goso Y, Ichikawa T, Hayashida H, Nakamura T, Kurihara M, et al. Immunohistochemical localization in rat gastrointestinal tract of a sialomucin species recognized by HCM31, a new anti-mucin monoclonal antibody. Biochem Res 2002; 23: 63–8
   Google Scholar
• Ishihara K, Kurihara M, Goso Y, Ota H, Katsuyama T, Hotta K. Establishment of monoclonal antibodies against carbohydrate moiety of gastric mucins distributed in the different sites and layers of rat gastric mucosa. Glycoconjugate J 1996; 13: 857–64
   PubMed Web of Science ®Google Scholar
• Tsubokawa D, Goso Y, Sawaguchi A, Kurihara M, Ichikawa T, Suganuma T, et al. An anti-mucin monoclonal antibody, PGM34, against 6-sulfated blood-group H type 2 antigen on the carbohydrate moiety of mucin. FEBS J 2007; 274: 1833–48
   PubMed Web of Science ®Google Scholar
• Ota H, Katsuyama T. Alternating laminated array of two types of mucin in the human gastric surface mucous layer. Histochem J 1992; 24: 86–92
   PubMedGoogle Scholar
• Goso Y, Endo M, Kurihara M, Ishihara K. Characterization of oligosaccharide epitope recognized by anti-mucin monoclonal antibody, RGM21, using neogrycoconjugate technology. Glycoconjugate J 2005;22:347 [ abstract].
   Google Scholar
• Ikezawa T, Goso Y, Ichikawa T, Hayashida H, Kurihara M, Ishihara K, et al. Appearance of specific mucins recognized by monoclonal antibodies in rat gastric mucosa healing from HCL-induced gastric mucosal damage. J Gastroenterol 2004; 39: 113–9
   PubMed Web of Science ®Google Scholar
• Goto T, Tomozawa N, Kobayashi E, Fujinuma A. A comparative pharmacology study between the intracolonic and oral routes of 5-FU administration in a colon cancer-bearing Yosida sarcoma rat model. J Pharmacol Sci 2004; 95: 163–73
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Ishihara K, Saigenji K, Hotta K. Effects of acid-inhibitory antiulcer drugs on mucin biosynthesis in the rat stomach. Eur J Pharmacol 1994; 251: 107–11
   PubMed Web of Science ®Google Scholar
• Sheahan DG, Jervis HR. Comparative histochemistry of gastrointestinal mucosubstances. Am J Anat 1976; 146: 103–31
   PubMedGoogle Scholar
• Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, et al. Natural antibiotic function of human gastric mucin against Helicobactor pylori infection. Science 2004; 305: 1003–6
   PubMed Web of Science ®Google Scholar
• Huang FS, Kemp CJ, Williams JL, Erwin CR, Warner BW. Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury. Am J Physiol Gastrointest Liver Physiol 2002; 282: 432–42
   PubMed Web of Science ®Google Scholar
• Kralovanszky J, Prajda N, Kerpel-Fronius S, Bagriji T, Kiss E, Peters GJ. Biochemical consequences of 5-fluorouracil gastrointestional toxicity in rats; effect of high-dose uridine. Cancer Chemother Pharmacol 1993; 32: 243–8
   PubMed Web of Science ®Google Scholar
• Inomata A, Horii I, Suzuki K. 5-Fluorouracil-induced intestinal toxicity: what determines the severity of damage to murine intestinal crypt epithelia. Toxicol Lett 2002; 133: 231–40
   PubMed Web of Science ®Google Scholar
• Potten CS. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metast Rev 1992; 11: 179–95
   PubMed Web of Science ®Google Scholar
• Hattori T Arizono N Cell kinetics and secretion of mucus in the gastrointestinal mucosa, and their diurnal rhythm. J Clin Gastroenterol 1988;10:1–6.
   Web of Science ®Google Scholar